Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
--------------------------------------------------------------------
Source: CNBC
Published: 2026-06-30 04:50 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Culture & Entertainment, Food & Agriculture, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned.
--------------------------------------------------------------------